PHI with Fibroadenoma
How does this condition affect your private health insurance?
Fibroadenoma is a common, benign (non-cancerous) breast tumor composed of glandular and stromal (connective) tissue. It often presents as a firm, rubbery, movable, and painless lump, most frequently in women aged 15-35. While typically harmless, it can grow. Diagnosis involves physical examination, imaging like ultrasound or mammogram, and sometimes a biopsy to confirm its benign nature. Management varies from watchful waiting with regular monitoring for smaller, stable lesions, to surgical excision if the lump is large, growing, causing discomfort, or if the diagnosis is uncertain. They rarely transform into malignancy.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Variable; often discovered as a stable lump that can persist for years, grow slowly, or remain static before diagnosis or removal.
Duration of Illness (Lifetime)
Often a one-time event for a specific lump, but new fibroadenomas can develop over a lifetime; generally benign and may resolve spontaneously or require removal.
Cost of Treatment (Initial)
Ranges from hundreds of USD (consultation, imaging) to several thousands of USD (biopsy, excisional surgery) if removal is performed.
Cost of Treatment (Lifetime)
Typically similar to first occurrence if new lesions arise; often low if managed conservatively with monitoring and no surgical intervention.
Mortality Rate
Extremely low, as fibroadenomas are benign tumors and not life-threatening.
Risk of Secondary Damages
Low; primarily psychological distress/anxiety due to cancer fear; minimal physical damage unless complications from surgery (e.g., infection, scarring) occur.
Probability of Full Recovery
Very high with diagnosis and appropriate management (excision or watchful waiting); recurrence of new fibroadenomas is possible, but the original lesion is typically resolved.
Underlying Disease Risk
Low for systemic underlying diseases; can coexist with other benign breast conditions, and rarely, complex fibroadenomas may slightly increase future breast cancer risk, but it's not an underlying disease itself.